Skip to Content
Merck
  • Synthesis and preliminary ex vivo evaluation of the spasmolytic activity of 1,3-thiazolium- and 1,3,4-thiadiazolium-5-methylthio- and 5-thioacetate derivatives.

Synthesis and preliminary ex vivo evaluation of the spasmolytic activity of 1,3-thiazolium- and 1,3,4-thiadiazolium-5-methylthio- and 5-thioacetate derivatives.

Acta pharmaceutica (Zagreb, Croatia) (2014-06-11)
José A S Luis, Thiago M De Aquino, Bruno F Lira, Petrônio F A Filho, Marcus T Scotti, Luciana Scotti, Ricardo O De Moura, Francisco J B Mendonça Junior
ABSTRACT

Seven new compounds have been synthetized in satisfactory yields (51-78 %) through the treatment of mesoionic 1,3-thiazolium-5-thiolate (4a-d) and 1,3,4-thiadiazolium- 5-thiolate (10a,b) with chloroacetic acid or methyl iodide: 1,3,4-thiadiazolium-5-methylthio- (11) and 5-thioacetate (12). The structure of the title compounds was elucidated by elemental analysis, IR, (1)H and (13)C NMR spectroscopy. The newly synthesized compounds 5a, 6a, 11 and 12 were evaluated for their ex vivo spasmolytic potential on four isolated smooth muscles (rat aorta and uterus, guinea pig ileum and trachea) and compared with scopolamine. Some of the compounds exhibited potent spasmolytic activity equal to or stronger than scopolamine.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Carbamoylcholine chloride, ≥98% (titration), crystalline
Supelco
(−)-Scopolamine hydrochloride, analytical standard
Sigma-Aldrich
Aluminum oxide, mesoporous, MSU-X (wormhole), average pore size 3.8 nm
Supelco
Aluminum oxide, activated, neutral, Brockmann Activity I
Carbachol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Acetylcholine chloride, ≥99% (TLC)
Sigma-Aldrich
Acetylcholine chloride, suitable for cell culture
Sigma-Aldrich
Oxytocin, lyophilized powder, ~15 IU/mg solid (Prepared from synthetic oxytocin)
Sigma-Aldrich
Oxytocin
Sigma-Aldrich
Aluminum oxide, nanopowder, <50 nm particle size (TEM)
Sigma-Aldrich
Aluminum oxide, nanowires, diam. × L 2-6 nm × 200-400 nm
Sigma-Aldrich
Aluminum oxide, nanopowder, 13 nm primary particle size (TEM), 99.8% trace metals basis
Sigma-Aldrich
Acetylcholine chloride, pkg of 150 mg (per vial)
Sigma-Aldrich
Arachidonic acid, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
Aluminum oxide, nanoparticles, <50 nm particle size (DLS), 20 wt. % in isopropanol
Sigma-Aldrich
Aluminum oxide, 99.997% trace metals basis
Supelco
Aluminum oxide, for the determination of hydrocarbons
Sigma-Aldrich
Arachidonic acid, >95.0% (GC)
Sigma-Aldrich
Aluminum oxide, pellets, 3 mm
Sigma-Aldrich
Aluminum oxide, pore size 58 Å, ~150 mesh
Sigma-Aldrich
Aluminum oxide, Type WN-6, Neutral, Activity Grade Super I
Sigma-Aldrich
Aluminum oxide, fused, powder, primarily α-phase, 100-200 mesh
Sigma-Aldrich
Aluminum oxide, Corundum, α-phase, -100 mesh
Sigma-Aldrich
Aluminum oxide, fused, powder, primarily α-phase, -325 mesh
Sigma-Aldrich
Aluminum oxide, powder, 99.99% trace metals basis
USP
Oxytocin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Aluminum oxide, powder, primarily α phase, ≤10 μm avg. part. size, 99.5% trace metals basis
Sigma-Aldrich
Aluminum oxide, activated, basic, Brockmann I
Sigma-Aldrich
Aluminum oxide, activated, acidic, Brockmann I
Sigma-Aldrich
Aluminum oxide, activated, neutral, Brockmann I